Drug Stocks in Spotlight (ELN, SNY, HLF, CI, MYL)

Houston, TX -- (SBWIRE) -- 02/07/2013 -- AnotherWinningTrade.com offers its daily alerts and market content newsletter to investors looking for the best information available! AnotherWinningTrade.com provides its subscribers with useful, timely information and exclusive alerts on penny stocks, mid cap stocks and large cap stocks with the potential to deliver gains of 100%-200% or more. We have the top alerts in the industry. To receive our FREE, comprehensive newsletter, visit AnotherWinningTrade.com.

Elan Corporation, plc (ADR)(NYSE:ELN) added 4.79% and is trading at $9.85. Elan Corporation, plc (Elan) is a neuroscience-based biotechnology company. The Company is focused on discovering and developing advanced therapies in neurodegenerative and autoimmune diseases.

Can ELN Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Sanofi SA (ADR)(NYSE:SNY) is lower 5.22% and is trading at $44.87. Sanofi SA, formerly Sanofi-Aventis, is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi focuses on the field of healthcare with six growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets and animal health.

How Should Investors Trade SNY After The Recent Volatile Moves? Find Out Here

Herbalife Ltd.(NYSE:HLF) added 2.07% and is trading at $36.53 Herbalife Ltd. is a global network marketing company that sells weight management, nutritional supplements, energy, sports and fitness products and personal care products through a network of approximately 2.7 million independent distributors, except in China, where the Company sells its products through retail stores.

Is HLF Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis Here

CIGNA Corporation(NYSE:CI) added 1.51% and is trading at $60.57. Cigna Corporation (Cigna) is a holding company. Cigna is a global health service company, with insurance subsidiaries that are providers of medical, dental, disability, life and accident insurance and related products and services.

Can CI Rebound After The Recent Slump and Investors Can Make Money? Find Out Here

Mylan Inc.(NASDAQ:MYL) is lower 0.12% and is trading at $28.77. Mylan, Inc. develops and markets generics along with a number of proprietary drugs. The Company's product is for the treatment of migraine headaches, an orphan drug for the on/off fluctuation in people with Parkinson's disease, and a wound care product to treat diabetic foot ulcers.

Is MYL Ready To Move Back To New Highs This Year? Find Out Here

Disclaimer
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information
Winning Media LLC
1-800-411-7716
ir@AnotherWinningTrade.com